Loading company…
Shenzhen-based AI drug discovery company whose Pyxir platform supports molecular design, virtual screening and optimization.
Established in 2019 and based in Shenzhen, China, Xingyao Technology uses artificial intelligence to support drug research and development, and it is a participant of Merck China Innovation Hub. Its Pyxir platform combines computational and medicinal chemistry, with modules for molecular design, attribute prediction, virtual screening and targeted optimization. The platform covers drug candidate discovery from target development through clinical services.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in